Our study (NCT04800133) aimed to determine the safety and immunogenicity in patients with IEIs receiving a 3-dose primary series of mRNA vaccine BNT162b2 (age 12+) or inactivated whole-virion vaccine CoronaVac (age 3+) in Hong Kong. including Omicron BA. 1 neutralization. in a nonrandomized manner. https://kyqvuli1r0nd.blog2freedom.com/34914474/on-the-potential-of-3d-transdimensional-surface-wave-tomography-for-geothermal-prospecting-of-the-reykjanes-peninsula